• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Lancet Regional Health-Western Pacific

    Lancet Regional Health-Western Pacific

    JournalISSN 2666-6065eISSN 2666-6065中科院 医学 1区

    年发文量

    研究主题

    论文(1882)

    排序
    1Machine Learning–based Prediction of 30-, 60-, and 90-Day Postoperative Mortality and Major Complications: an 11-Year Population-Based Cohort Study in Hong Kong
    Yuchen Wei, Wenze Zhang,Guozhang Lin,Conglu Li,Thomas Yuen Tung Lam,Chi Tim Hung,Eman Leung,Eng Kiong Yeoh,Ka Chun Chong, Yue Sun Cheung,Paul Bo San Lai

    Background Existing surgical risk prediction tools are often limited by short-term outcomes. Our study aimed to develop and validate perioperative models and preoperative models for predicting mortality and major complications using surgical data from Hong Kong. Methods This population-based retrospective cohort study analysed 11 years of surgical data (July 2014–June 2024) collected from 17 public hospitals in Hong Kong. Of 124 clinically relevant candidate predictors, 67 predictors were retained for the perioperative full models. To improve clinical usability and facilitate preoperative risk assessment, reduced preoperative models were trained using 13 predictors. Separate models were developed for emergency and elective surgery. Primary outcomes were 30-day, 60-day, and 90-day all-cause mortality in emergency and elective surgery cohorts. Secondary outcomes included 30-day major surgical-related and medical-related complications. Multiple risk prediction models were evaluated using training data from 2014 to 2021 with 5-fold stratified cross-validation, while temporal external validation was performed using data from 2022 to 2024. Performance was assessed using the area under the receiver operating characteristic curve (AUROC), area under the precision–recall curve (AUPRC), Brier score, calibration intercept and slope, integrated calibration index (ICI), E50, and E90. SHAP was used for model interpretation. Models showing poor calibration underwent logistic recalibration using five-fold out-of-fold development predictions. Findings 43,601 subjects were included in the training set and 16,143 in the external validation set for emergency surgeries, whereas 151,016 subjects were used for training and 37,586 for external validation for elective surgeries. In temporal validation, the perioperative full models achieved AUROCs of 0.89, 0.89, and 0.89 for 30-day, 60-day, and 90-day mortality after emergency surgery and 0.91, 0.90, and 0.90 after elective surgery. Corresponding AUPRCs were 0.27, 0.36, and 0.41 for emergency surgery and 0.05, 0.10, and 0.13 for elective surgery. AUROCs for medical- and surgery-related complications were 0.88 and 0.78 in emergency surgery and 0.87 and 0.80 in elective surgery. The 13-predictor preoperative models retained useful discrimination, although performance was lower than that of the perioperative full models. Calibration assessment indicated variable agreement between predicted and observed risks, supporting the need for recalibration before clinical implementation. Eight complication-specific models showed validation AUROCs ranging from 0.75 to 0.94. SHAP analysis revealed clinically plausible risk factors, such as higher ASA status, abnormal laboratory results (such as renal dysfunction and low albumin), and surgical complexity. Logistic recalibration improved Brier scores and calibration indices across all full and reduced models without changing AUROC or AUPRC. Interpretation We have developed and validated comprehensive surgical risk prediction models with excellent discrimination and robust performance using 11 years of population-based data from Hong Kong. The identified predictors were clinically interpretable, which can serve as a data-driven tool to assist clinicians and patients for surgical risk assessments. Funding Health and Medical Research Fund (21220531) and National Natural Science Foundation of China (72574190).

    2026
    引用
    AI阅读
    加入学术空间
    2Lessons from Cambodia: Developing a National Evidence-Based Policy and Strategic Plan for Surgical, Obstetric, and Anaesthesia Care
    Abbas A. Karim, Kim Savuon, Mean Reatanak Sambath,Kee B. Park, Lem Dara
    2026
    引用
    AI阅读
    加入学术空间
    3How Peptides Are Augmenting Eating Disorder Risk
    Timothy Piatkowski,Kyle T. Ganson,Jason M. Nagata
    2026
    引用
    AI阅读
    加入学术空间
    4Evaluation of the Urine-Based Fujifilm SILVAMP TB LAM II Assay for Diagnosis of Pulmonary Tuberculosis in Facility-Based and Community-Based Settings in Vietnam: a Multicentre Diagnostic Accuracy Study
    Han Thi Nguyen,Luan Nguyen Quang Vo,Andrew James Codlin,Nga Thi Thuy Nguyen,Rachel Forse,Jacob Creswell,Hoa Binh Nguyen,Cuong Kim Nguyen,Luong Van Dinh,Ha Thu Doan,Ha Thi Minh Dang,Lan Huu Nguyen,

    Background Closing the tuberculosis (TB) diagnostic gap requires accessible non-sputum-based point-of-care testing. The Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM I) assay was a promising tool but showed lot-to-lot variability. Following a redesign, we evaluated the second-generation assay (FujiLAM II) in people living with HIV (PLHIV) and HIV-negative individuals, across varying care settings. Methods We combined two prospective multicentre studies in Vietnam, recruiting adults with presumptive TB identified through facility- and community-based screening. Participants gave urine for FujiLAM II testing and sputum specimens for testing with the Xpert MTB/RIF Ultra assay (Xpert–Ultra) and, in one study, mycobacterial culture. We calculated sensitivity and specificity of FujiLAM II against culture and a microbiological reference standard (MRS), defined as positivity on culture and/or Xpert–Ultra. Findings Among 3087 participants, 563 (18.2%) had TB by MRS and 684 (22.2%) were PLHIV. Against culture, sensitivity of FujiLAM II was 30.5% (95% CI 25.8–35.6%) and specificity 99.3% (95% CI 98.8–99.6%); against MRS, sensitivity was 29.5% (95% CI 25.7–33.4%) and specificity 99.3% (95% CI 98.9–99.6%). Culture-based sensitivity was lower during community-based screening, compared with facility-based screening (10.5%, 95% CI 1.3–33.1% versus 31.6%, 95% CI 26.7–36.9%). MRS-based sensitivity of the test was higher among PLHIV (52.9%, 95% CI 38.5–67.1) than HIV-negative (27.1%, 95% CI 23.3–31.2), especially with CD4 < 200 cells/μL (78.9%, 95% CI 54.4–93.9%). Interpretation FujiLAM II exhibited high specificity but limited sensitivity. Sensitivity was highest among PLHIV with advanced immunosuppression and remained low in HIV-negative individuals and during community-based screening. These findings align with WHO recommendations for targeted urine-LAM use. Funding The Stop TB Partnership’s TB REACH initiative, with funds from Global Affairs Canada; Unitaid; Fujifilm (in-kind donation of tests).

    2026
    引用
    AI阅读
    加入学术空间
    5Could Food is Medicine Offer a Healthcare-Led Pathway to Improve Nutrition and Health Equity in the Western Pacific?
    Jason H.Y. Wu, Megan L. Gow,Kristy K. Law, Sophia Zoungas,Hee-Sook Lim,Lee-Ling Lim,Maoyi Tian, Isabella Kamariza, Amy Deptford, Zuzanna Zielinska, Sarah Stern,Dariush Mozaffarian

    Poor diet quality is a leading driver of noncommunicable diseases (NCDs) and growing health and economic burden across the Western Pacific region, yet nutrition remains under-integrated within healthcare systems. Food is Medicine (FIM) programs — defined as integration of the provision or subsidisation of healthy food directly into healthcare delivery and financing to prevent or manage diet-sensitive diseases — offer a promising, healthcare-led approach to address diet-related conditions, improve health equity, catalyse local food production, and support transitions towards sustainable food systems. This Viewpoint examines the relevance and potential of FIM in the Western Pacific, summarising core program components and emerging global evidence demonstrating improvements in diet quality, food security, clinical outcomes, and healthcare utilisation. We highlight strong cultural, policy, and healthcare system alignment that may support regional adaptation, alongside potential implementation challenges, including health system constraints, food system vulnerabilities, and limited local evidence. Finally, we propose pragmatic building blocks to guide early-stage design, implementation, and evaluation of FIM programs tailored to diverse regional contexts.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1882 篇论文

    高被引作者

    作者引用发文
    Ourlad Alzeus Gaddi Tantengco5936
    Erlidia F Llamas-Clark5561
    Ryan C. V. Lintao5561
    Liqun Fang45910
    Zhongjie Li4335
    Michael Baker42510
    Maigeng Zhou41027
    Lei Zhang40912
    Pengpeng Ye38721
    George Fu Gao3677

    高产作者

    作者引用发文
    The Lancet Regional Health – Western Pacific13045
    Maigeng Zhou41027
    Peng Yin36225
    Pengpeng Ye38721
    Zhengming Chen34019
    Liming Li25517
    Yiping Chen20516
    John S. Ji33116
    Benjamin Howden18015
    Canqing Yu20115

    相关期刊

    European Journal of Epidemiology
    International journal of epidemiology
    Medical Journal Of Australia
    Public Health
    Epidemiology and health
    Journal of epidemiology and global health
    The Lancet. Global health
    Journal of Global Health
    Archives of public health
    LANCET REGIONAL HEALTH-EUROPE